106 related articles for article (PubMed ID: 28323962)
1. MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; Dreijerink KM; Ausems MG; Beijers HJ; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Peeters PHM; Pijnappel RM; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2017 Jun; 102(6):2083-2090. PubMed ID: 28323962
[TBL] [Abstract][Full Text] [Related]
2. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
[TBL] [Abstract][Full Text] [Related]
3. High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; Pieterman CRC; Bleiker EMA; Dekkers OM; van der Horst-Schrivers AN; Hermus AR; de Herder WW; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2018 Jun; 103(6):2354-2361. PubMed ID: 29618015
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
5. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in MEN1 - a cancer genetics perspective.
Brennan P
Clin Endocrinol (Oxf); 2015 Mar; 82(3):327-229. PubMed ID: 25279812
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 (MEN1) in Austria.
Weinhäusel A; Kaserer K; Vierhapper H; Niederle B; Haas OA;
Wien Klin Wochenschr; 2002 Apr; 114(7):252-7. PubMed ID: 12089860
[TBL] [Abstract][Full Text] [Related]
9. [Referral for mammography often not according to guideline].
Lodder-van der Vlies D; Droogh-de Greve K; de Win JL; van der Zaag-Loonen HJ; van Bruggen JA; Markestein HP; Gratama JW
Ned Tijdschr Geneeskd; 2015; 159():A8636. PubMed ID: 25804111
[TBL] [Abstract][Full Text] [Related]
10. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
[TBL] [Abstract][Full Text] [Related]
11. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
[TBL] [Abstract][Full Text] [Related]
12. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
[TBL] [Abstract][Full Text] [Related]
13. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
de Laat JM; Dekkers OM; Pieterman CR; Kluijfhout WP; Hermus AR; Pereira AM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; de Herder WW; Valk GD
J Clin Endocrinol Metab; 2015 Sep; 100(9):3288-96. PubMed ID: 26126205
[TBL] [Abstract][Full Text] [Related]
15. Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.
Saadatmand S; Vos JR; Hooning MJ; Oosterwijk JC; Koppert LB; de Bock GH; Ausems MG; van Asperen CJ; Aalfs CM; Gómez Garcia EB; Meijers-Heijboer H; Hoogerbrugge N; Piek M; Seynaeve C; Verhoef C; Rookus M; Tilanus-Linthorst MM;
Int J Cancer; 2014 Dec; 135(12):2940-9. PubMed ID: 24789418
[TBL] [Abstract][Full Text] [Related]
16. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1).
Karges W; Schaaf L; Dralle H; Boehm BO
Exp Clin Endocrinol Diabetes; 2000; 108(5):334-40. PubMed ID: 10989951
[TBL] [Abstract][Full Text] [Related]
17. Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1.
van Leeuwaarde RS; Pieterman CRC; May AM; Dekkers OM; van der Horst-Schrivers AN; Hermus AR; de Herder WW; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
Neuroendocrinology; 2021; 111(3):288-296. PubMed ID: 32365349
[TBL] [Abstract][Full Text] [Related]
18. Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1.
Toledo RA; Lourenço DM; Coutinho FL; Quedas E; Mackowiack I; Machado MC; Montenegro F; Cunha-Neto MB; Liberman B; Pereira MA; Correa PH; Toledo SP
Clin Endocrinol (Oxf); 2007 Sep; 67(3):377-84. PubMed ID: 17555499
[TBL] [Abstract][Full Text] [Related]
19. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
20. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation.
Giraud S; Choplin H; Teh BT; Lespinasse J; Jouvet A; Labat-Moleur F; Lenoir G; Hamon B; Hamon P; Calender A
J Clin Endocrinol Metab; 1997 Oct; 82(10):3487-92. PubMed ID: 9329390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
